Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

Get the latest news on Autolus Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Autolus Therapeutics performance ...

Dave Parker, a hard-hitting outfielder who was set to be inducted into the Baseball Hall of Fame next month, has died, the ...

Omeros Corporation (Nasdaq: OMER) today announced the recent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for narsoplimab for the treatment of hemat ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be approved in combination with ...

Regulators and manufacturers advance biosimilars for aflibercept, omalizumab, and dupilumab, enhancing access to treatment in ...

The Committee for Medicinal Products for Human Use (CHMP) has recommended that the drug be authorised to treat unresectable ...

Pediatric infliximab biosimilar use has risen significantly, reflecting evolving treatment patterns in inflammatory bowel ...

Thiogenesis Therapeutics, Inc. (TSXV: TTI) (OTCQX: TTIPF), a clinical-stage biopharmaceutical company developing next-generation thiol-based therapies for mitochondrial disease and pediatric metabolic ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee ...

CHMP recommends approval of Novo Nordisk’s Ozempic for peripheral arterial disease: Bagsværd, Denmark Wednesday, June 25, 2025, 15:00 Hrs [IST] Novo Nordisk, a leading global h ...